At present, the incidence and fatality rate of lung cancer in China rank first among all malignant tumors. Despite the continuous development and improvement of China's medical level, the overall 5-year survival rate of lung cancer patients is still lower than 20% and is staged. A number of studies have confirmed that early diagnosis and treatment of early stage lung cancer is of great significance to improve the prognosis of patients. In recent years, artificial intelligence technology has gradually begun to be applied in oncology. ai is used in cancer screening, clinical diagnosis, radiation therapy (image acquisition, at-risk organ segmentation, image calibration and delivery) and other aspects of rapid development. However, whether medical ai can be socialized depends on the public's attitude and acceptance to a certain extent. However, at present, there are few studies on the diagnosis of early lung cancer by AI technology combined with SCT scanning. In view of this, this study applied the combined method in early lung cancer screening, aiming to find a safe and efficient screening mode and provide a reference for clinical diagnosis and treatment.
Cancer is the uncontrollable cell division of abnormal cells inside the human body, which can spread to other body organs. It is one of the non-communicable diseases (NCDs) and NCDs accounts for 71% of total deaths worldwide whereas lung cancer is the second most diagnosed cancer after female breast cancer. Cancer survival rate of lung cancer is only 19%. There are various methods for the diagnosis of lung cancer, such as X-ray, CT scan, PET-CT scan, bronchoscopy and biopsy. However, to know the subtype of lung cancer based on the tissue type H and E staining is widely used, where the staining is done on the tissue aspirated from a biopsy. Studies have reported that the type of histology is associated with prognosis and treatment in lung cancer. Therefore, early and accurate detection of lung cancer histology is an urgent need and as its treatment is dependent on the type of histology, molecular profile and stage of the disease, it is most essential to analyse the histopathology images of lung cancer. Hence, to speed up the vital process of diagnosis of lung cancer and reduce the burden on pathologists, Deep learning techniques are used. These techniques have shown improved efficac
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths worldwide. Survival largely depends on tumor stage at diagnosis, and early detection with low-dose CT can significantly reduce mortality in high-risk patients. AI can improve the detection, measurement, and characterization of pulmonary nodules while reducing assessment time. However, the training data, functionality, and performance of available AI systems vary considerably, complicating software selection and regulatory evaluation. Manufacturers must specify intended use and provide test statistics, but they can choose their training and test data, limiting standardization and comparability. Under the EU AI Act, consistent quality assurance is required for AI-based nodule detection, measurement, and characterization. This position paper proposes systematic quality assurance grounded in a validated reference dataset, including real screening cases plus phantom data to verify volume and growth rate measurements. Regular updates shall reflect demographic shifts and technological advances, ensuring ongoing relevance. Consequently, ongoing AI quality assurance is vital. Regulatory challenges ar
Lung cancer is the leading cause of cancer-related mortality in adults worldwide. Screening high-risk individuals with annual low-dose CT (LDCT) can support earlier detection and reduce deaths, but widespread implementation may strain the already limited radiology workforce. AI models have shown potential in estimating lung cancer risk from LDCT scans. However, high-risk populations for lung cancer are diverse, and these models' performance across demographic groups remains an open question. In this study, we drew on the considerations on confounding factors and ethically significant biases outlined in the JustEFAB framework to evaluate potential performance disparities and fairness in two deep learning risk estimation models for lung cancer screening: the Sybil lung cancer risk model and the Venkadesh21 nodule risk estimator. We also examined disparities in the PanCan2b logistic regression model recommended in the British Thoracic Society nodule management guideline. Both deep learning models were trained on data from the US-based National Lung Screening Trial (NLST), and assessed on a held-out NLST validation set. We evaluated AUROC, sensitivity, and specificity across demographi
Vision transformer-based methods are advancing the field of medical artificial intelligence and cancer imaging, including lung cancer applications. Recently, many researchers have developed vision transformer-based AI methods for lung cancer diagnosis and prognosis. This scoping review aims to identify the recent developments on vision transformer-based AI methods for lung cancer imaging applications. It provides key insights into how vision transformers complemented the performance of AI and deep learning methods for lung cancer. Furthermore, the review also identifies the datasets that contributed to advancing the field. Of the 314 retrieved studies, this review included 34 studies published from 2020 to 2022. The most commonly addressed task in these studies was the classification of lung cancer types, such as lung squamous cell carcinoma versus lung adenocarcinoma, and identifying benign versus malignant pulmonary nodules. Other applications included survival prediction of lung cancer patients and segmentation of lungs. The studies lacked clear strategies for clinical transformation. SWIN transformer was a popular choice of the researchers; however, many other architectures wer
Background: Lung cancer was known as primary cancers and the survival rate of cancer is about 15%. Early detection of lung cancer is the leading factor in survival rate. All symptoms (features) of lung cancer do not appear until the cancer spreads to other areas. It needs an accurate early detection of lung cancer, for increasing the survival rate. For accurate detection, it need characterizes efficient features and delete redundancy features among all features. Feature selection is the problem of selecting informative features among all features. Materials and Methods: Lung cancer database consist of 32 patient records with 57 features. This database collected by Hong and Youngand indexed in the University of California Irvine repository. Experimental contents include the extracted from the clinical data and X-ray data, etc. The data described 3 types of pathological lung cancers and all features are taking an integer value 0-3. In our study, new method is proposed for identify efficient features of lung cancer. It is based on Hyper-Heuristic. Results: We obtained an accuracy of 80.63% using reduced 11 feature set. The proposed method compare to the accuracy of 5 machine learning
Large language models (LLMs) have demonstrated remarkable capabilities, but their success heavily relies on the quality of pretraining corpora. For Chinese LLMs, the scarcity of high-quality Chinese datasets presents a significant challenge, often limiting their performance. To address this issue, we propose the OpenCSG Chinese Corpus, a series of high-quality datasets specifically designed for LLM pretraining, post-training, and fine-tuning. This corpus includes Fineweb-edu-chinese, Fineweb-edu-chinese-v2, Cosmopedia-chinese, and Smoltalk-chinese, each with distinct characteristics: Fineweb-edu datasets focus on filtered, high-quality content derived from diverse Chinese web sources; Cosmopedia-chinese provides synthetic, textbook-style data for knowledge-intensive training; and Smoltalk-chinese emphasizes stylistic and diverse chat-format data. The OpenCSG Chinese Corpus is characterized by its high-quality text, diverse coverage across domains, and scalable, reproducible data curation processes. Additionally, we conducted extensive experimental analyses, including evaluations on smaller parameter models, which demonstrated significant performance improvements in tasks such as C-
Periodontitis and dental caries are common oral diseases affecting billions globally. While observational studies suggest links between these conditions and lung cancer, causality remains uncertain. This study used two sample Mendelian randomization (MR) to explore causal relationships between dental traits (periodontitis, dental caries) and lung cancer subtypes, and to assess mediation by pulmonary function. Genetic instruments were derived from the largest available genome wide association studies, including data from 487,823 dental caries and 506,594 periodontitis cases, as well as lung cancer data from the Transdisciplinary Research of Cancer in Lung consortium. Inverse variance weighting was the main analytical method; lung function mediation was assessed using the delta method. The results showed a significant positive causal effect of dental caries on overall lung cancer and its subtypes. Specifically, a one standard deviation increase in dental caries incidence was associated with a 188.0% higher risk of squamous cell lung carcinoma (OR = 2.880, 95% CI = 1.236--6.713, p = 0.014), partially mediated by declines in forced vital capacity (FVC) and forced expiratory volume in o
Due to silence in early stages, lung cancer has been one of the most leading causes of mortality in cancer patients world-wide. Moreover, major symptoms of lung cancer are hard to differentiate with other respiratory disease symptoms such as COPD, further leading patients to overlook cancer progression in early stages. Thus, to enhance survival rates in lung cancer, early detection from consistent proactive respiratory system monitoring becomes crucial. One of the most prevalent and effective methods for lung cancer monitoring would be low-dose computed tomography(LDCT) chest scans, which led to remarkable enhancements in lung cancer detection or tumor classification tasks under rapid advancements and applications of computer vision based AI models such as EfficientNet or ResNet in image processing. However, though advanced CNN models under transfer learning or ViT based models led to high performing lung cancer detections, due to its intrinsic limitations in terms of correlation dependence and low interpretability due to complexity, expansions of deep learning models to lung cancer treatment analysis or causal intervention analysis simulations are still limited. Therefore, this re
Objectives: Lung cancer remains a significant global public health challenge and is still one of the leading cause of cancer-related death in Argentina. This study aims to assess the disease and economic burden of lung cancer in the country. Study design: Burden of disease study Methods. A mathematical model was developed to estimate the disease burden and direct medical cost attributable to lung cancer. Epidemiological parameters were obtained from local statistics, the Global Cancer Observatory, the Global Burden of Disease databases, and a literature review. Direct medical costs were estimated through micro-costing. Costs were expressed in US dollars (US$), April 2023 (1 US$ =216.38 argentine pesos). A second-order Monte Carlo simulation was performed to estimate the uncertainty. Results: Considering approximately 10,000 deaths, 12,000 incident cases, and 14,000 5-year prevalent cases, the economic burden of lung cancer in Argentina in 2023 was estimated to be US$ 556.20 million (396.96 -718.20), approximately 1.4% of the total healthcare expenditure for the country. The cost increased with a higher stage of the disease and the main driver was the drug acquisition (80%). 179,046
Objectives: The present study evaluated the impact of a commercially available explainable AI algorithm in augmenting the ability of clinicians to identify lung cancer on chest X-rays (CXR). Design: This retrospective study evaluated the performance of 11 clinicians for detecting lung cancer from chest radiographs, with and without assistance from a commercially available AI algorithm (red dot, Behold.ai) that predicts suspected lung cancer from CXRs. Clinician performance was evaluated against clinically confirmed diagnoses. Setting: The study analysed anonymised patient data from an NHS hospital; the dataset consisted of 400 chest radiographs from adult patients (18 years and above) who had a CXR performed in 2020, with corresponding clinical text reports. Participants: A panel of readers consisting of 11 clinicians (consultant radiologists, radiologist trainees and reporting radiographers) participated in this study. Main outcome measures: Overall accuracy, sensitivity, specificity and precision for detecting lung cancer on CXRs by clinicians, with and without AI input. Agreement rates between clinicians and performance standard deviation were also evaluated, with and without AI
Lung cancer begins in the lungs and leading to the reason of cancer demise amid population in the creation. According to the American Cancer Society, which estimates about 27% of the deaths because of cancer. In the early phase of its evolution, lung cancer does not cause any symptoms usually. Many of the patients have been diagnosed in a developed phase where symptoms become more prominent, that results in poor curative treatment and high mortality rate. Computer Aided Detection systems are used to achieve greater accuracies for the lung cancer diagnosis. In this research exertion, we proposed a novel methodology for lung Segmentation on the basis of Fuzzy C-Means Clustering, Adaptive Thresholding, and Segmentation of Active Contour Model. The experimental results are analysed and presented.
Lung cancer (LC) is a leading cause of cancer-related mortality in the United States. Accurate prediction of LC mortality rates is crucial for guiding targeted interventions and addressing health disparities. Although traditional regression-based models have been commonly used, explainable machine learning models may offer enhanced predictive accuracy and deeper insights into the factors influencing LC mortality. This study applied three models: random forest (RF), gradient boosting regression (GBR), and linear regression (LR) to predict county-level LC mortality rates across the United States. Model performance was evaluated using R-squared and root mean squared error (RMSE). Shapley Additive Explanations (SHAP) values were used to determine variable importance and their directional impact. Geographic disparities in LC mortality were analyzed through Getis-Ord (Gi*) hotspot analysis. The RF model outperformed both GBR and LR, achieving an R2 value of 41.9% and an RMSE of 12.8. SHAP analysis identified smoking rate as the most important predictor, followed by median home value and the percentage of the Hispanic ethnic population. Spatial analysis revealed significant clusters of el
Early detection of malignant lung nodules remains constrained by size and growth based screening criteria, often delaying diagnosis. We present an integrated AI system that jointly performs nodule detection and malignancy assessment directly at the nodule level from low dose CT scans, within a unified CADe/CADx framework. Unlike conventional pipelines separating detection and diagnosis, our approach targets malignant nodules directly, redefining evaluation at the point where clinical decisions are made. To address limitations in dataset scale and explainability, the system consists of a Large Ensemble Model (LEM) combining ensembles of shallow deep learning and feature based models. It was trained and evaluated on 25,709 scans with 69,449 annotated nodules, with external validation on an independent cohort. It achieved an AUC of 0.98 internally and 0.945 externally, outperforming all growth based metrics, Lung RADS size based triage, European volume and VDT based screening criteria, radiologists, and leading AI models. The model maintains high sensitivity at low false positive rates, excels for small and early stage cancers, and enables malignancy assessment up to one year earlier
Lung cancer is a leading cause of cancer-related deaths globally, where early detection and accurate diagnosis are critical for improving survival rates. While deep learning, particularly convolutional neural networks (CNNs), has revolutionized medical image analysis by detecting subtle patterns indicative of early-stage lung cancer, its adoption faces challenges. These models are often computationally expensive and require significant resources, making them unsuitable for resource constrained environments. Additionally, their lack of transparency hinders trust and broader adoption in sensitive fields like healthcare. Knowledge distillation addresses these challenges by transferring knowledge from large, complex models (teachers) to smaller, lightweight models (students). We propose a knowledge distillation-based approach for lung cancer detection, incorporating explainable AI (XAI) techniques to enhance model transparency. Eight CNNs, including ResNet50, EfficientNetB0, EfficientNetB3, and VGG16, are evaluated as teacher models. We developed and trained a lightweight student model, Distilled Custom Student Network (DCSNet) using ResNet50 as the teacher. This approach not only ensu
Deep learning models show significant potential for advancing AI-assisted medical diagnostics, particularly in detecting lung cancer through medical image modalities such as chest X-rays. However, the black-box nature of these models poses challenges to their interpretability and trustworthiness, limiting their adoption in clinical practice. This study examines both the interpretability and robustness of a high-performing lung cancer detection model based on InceptionV3, utilizing a public dataset of chest X-rays and radiological reports. We evaluate the clinical utility of multiple explainable AI (XAI) techniques, including both post-hoc and ante-hoc approaches, and find that existing methods often fail to provide clinically relevant explanations, displaying inconsistencies and divergence from expert radiologist assessments. To address these limitations, we collaborated with a radiologist to define diagnosis-specific clinical concepts and developed ClinicXAI, an expert-driven approach leveraging the concept bottleneck methodology. ClinicXAI generated clinically meaningful explanations which closely aligned with the practical requirements of clinicians while maintaining high diagno
Generative AI has recently had a profound impact on various fields, including daily life, research, and education. To explore its efficient utilization in data-driven materials science, we organized a hackathon -- AIMHack2024 -- in July 2024. In this hackathon, researchers from fields such as materials science, information science, bioinformatics, and condensed matter physics worked together to explore how generative AI can facilitate research and education. Based on the results of the hackathon, this paper presents topics related to (1) conducting AI-assisted software trials, (2) building AI tutors for software, and (3) developing GUI applications for software. While generative AI continues to evolve rapidly, this paper provides an early record of its application in data-driven materials science and highlights strategies for integrating AI into research and education.
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. Conventional computed tomography (CT) imaging, while essential for detection and staging, has limitations in distinguishing benign from malignant lesions and providing interpretable diagnostic insights. To address this challenge, this study proposes a dual-modal artificial intelligence framework that integrates CT radiology with hematoxylin and eosin (H&E) histopathology for lung cancer diagnosis and subtype classification. The system employs convolutional neural networks to extract radiologic and histopathologic features and incorporates clinical metadata to improve robustness. Predictions from both modalities are fused using a weighted decision-level integration mechanism to classify adenocarcinoma, squamous cell carcinoma, large cell carcinoma, small cell lung cancer, and normal tissue. Explainable AI techniques including Grad-CAM, Grad-CAM++, Integrated Gradients, Occlusion, Saliency Maps, and SmoothGrad are applied to provide visual interpretability. Experimental results show strong performance with accuracy up to 0.87, AUROC above 0.97, and macro F1-score of 0.88. Grad-CAM++ achieved the
Lung cancer is an extremely lethal disease primarily due to its late-stage diagnosis and significant mortality rate, making it the major cause of cancer-related demises globally. Machine Learning (ML) and Convolution Neural network (CNN) based Deep Learning (DL) techniques are primarily used for precise segmentation and classification of cancerous nodules in the CT (Computed Tomography) or MRI images. This study introduces an innovative approach to lung nodule segmentation by utilizing the Segment Anything Model (SAM) combined with transfer learning techniques. Precise segmentation of lung nodules is crucial for the early detection of lung cancer. The proposed method leverages Bounding Box prompts and a vision transformer model to enhance segmentation performance, achieving high accuracy, Dice Similarity Coefficient (DSC) and Intersection over Union (IoU) metrics. The integration of SAM and Transfer Learning significantly improves Computer-Aided Detection (CAD) systems in medical imaging, particularly for lung cancer diagnosis. The findings demonstrate the proposed model effectiveness in precisely segmenting lung nodules from CT scans, underscoring its potential to advance early de
Lung cancer remains one of the most prevalent and fatal diseases worldwide, demanding accurate and timely diagnosis and treatment. Recent advancements in large AI models have significantly enhanced medical image understanding and clinical decision-making. This review systematically surveys the state-of-the-art in applying large AI models to lung cancer screening, diagnosis, prognosis, and treatment. We categorize existing models into modality-specific encoders, encoder-decoder frameworks, and joint encoder architectures, highlighting key examples such as CLIP, BLIP, Flamingo, BioViL-T, and GLoRIA. We further examine their performance in multimodal learning tasks using benchmark datasets like LIDC-IDRI, NLST, and MIMIC-CXR. Applications span pulmonary nodule detection, gene mutation prediction, multi-omics integration, and personalized treatment planning, with emerging evidence of clinical deployment and validation. Finally, we discuss current limitations in generalizability, interpretability, and regulatory compliance, proposing future directions for building scalable, explainable, and clinically integrated AI systems. Our review underscores the transformative potential of large AI